Eupraxia Pharmaceuticals (EPRX.TO) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.59
-0.45
-0.31
-0.17

Details

Expected EPS
-0.181240776515916
Actual EPS
-0.17259333139731148
Surprise EPS
0.01
Surprise Percent
+4.77%

Description

Eupraxia Pharmaceuticals (EPRX.TO) has reported earnings of -0.17259333139731148 per share for Q4 2024.

0 Comments

Share your thoughts